Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ESCITALOPRAM OXALATE Cause Cardiotoxicity? 15 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Cardiotoxicity have been filed in association with ESCITALOPRAM OXALATE (Escitalopram). This represents 0.1% of all adverse event reports for ESCITALOPRAM OXALATE.

15
Reports of Cardiotoxicity with ESCITALOPRAM OXALATE
0.1%
of all ESCITALOPRAM OXALATE reports
6
Deaths
11
Hospitalizations

How Dangerous Is Cardiotoxicity From ESCITALOPRAM OXALATE?

Of the 15 reports, 6 (40.0%) resulted in death, 11 (73.3%) required hospitalization, and 11 (73.3%) were considered life-threatening.

Is Cardiotoxicity Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ESCITALOPRAM OXALATE. However, 15 reports have been filed with the FAERS database.

What Other Side Effects Does ESCITALOPRAM OXALATE Cause?

Drug ineffective (2,792) Anxiety (1,686) Headache (1,643) Somnolence (1,640) Nausea (1,635) Completed suicide (1,504) Drug interaction (1,477) Toxicity to various agents (1,446) Fatigue (1,443) Off label use (1,422)

What Other Drugs Cause Cardiotoxicity?

DOXORUBICIN (1,366) CYCLOPHOSPHAMIDE (1,009) TRASTUZUMAB (950) VINCRISTINE (446) FLUOROURACIL (425) RITUXIMAB (389) ETOPOSIDE (366) CAPECITABINE (307) TOCILIZUMAB (278) PREDNISONE (277)

Which ESCITALOPRAM OXALATE Alternatives Have Lower Cardiotoxicity Risk?

ESCITALOPRAM OXALATE vs ESKETAMINE ESCITALOPRAM OXALATE vs ESLICARBAZEPINE ESCITALOPRAM OXALATE vs ESMOLOL ESCITALOPRAM OXALATE vs ESOMEPRAZOLE ESCITALOPRAM OXALATE vs ESOMEPRAZOLE\ESOMEPRAZOLE\ESOMEPRAZOLE

Related Pages

ESCITALOPRAM OXALATE Full Profile All Cardiotoxicity Reports All Drugs Causing Cardiotoxicity ESCITALOPRAM OXALATE Demographics